Followers | 3 |
Posts | 1369 |
Boards Moderated | 0 |
Alias Born | 02/07/2016 |

Monday, March 17, 2025 11:47:12 AM
The real bottom line is that any reasonable person looking at the the patent disagreement with Merck and reading their filiny has opined in favor of Halozyme. Look at the WSJ, Barons, Cowen's and Morgan Stanley (I tried to paste they opinion on this board but it does't let me). Read tge filings that I posted on this board for yourself or have any AI platform summerize them for you. You will see that halo has a far stronger position. Don't take my words for it. Read the references or look at how the market participants have voted with their money so far.
Recent HALO News
- Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation • PR Newswire (US) • 04/24/2025 12:30:00 PM
- Halozyme Announces FDA Approval of argenx's VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy • PR Newswire (US) • 04/10/2025 10:15:00 PM
- European Commission Approved Subcutaneous DARZALEX® (daratumumab)-based Quadruplet Regimen for the Treatment of Patients with Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility • PR Newswire (US) • 04/09/2025 12:45:00 PM
- European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer • PR Newswire (US) • 04/07/2025 01:29:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 10:32:16 PM
- Halozyme Announces Bristol Myers Squibb Received Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) with ENHANZE® Across Multiple Solid Tumor Indications • PR Newswire (US) • 03/31/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 08:03:19 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/18/2025 08:17:06 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/18/2025 08:14:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/18/2025 08:10:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2025 01:46:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2025 11:32:38 PM
- Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference • PR Newswire (US) • 02/26/2025 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/25/2025 09:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2025 10:11:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2025 10:07:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2025 10:04:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2025 10:01:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2025 11:52:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2025 11:50:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2025 11:49:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2025 11:47:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 11:41:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 11:39:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 11:37:51 PM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com • INND • Apr 24, 2025 8:00 AM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM